Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Safety and Efficacy of Durvalumab With or Without Tremeli... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1–Low/Negative Recurrent or Metastatic HNSCC
0
Authors
Lillian Siu
20 more
Lillian Siu
•
Caroline Even
18 more
•
Jérôme Fayette
Published
November 1, 2018
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
JAMA Oncology
Topics
Medicine
Cancer Oncology
Internal Medicine
Pulmonary And Respiratory Medicine
Psychiatry And Mental Health
Show all topics
DOI
10.1001/jamaoncol.2018.4628
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
JAMA Oncology
Topics
Medicine
Cancer Oncology
Internal Medicine
Pulmonary And Respiratory Medicine
Psychiatry And Mental Health
Show all topics
DOI
10.1001/jamaoncol.2018.4628
Other Formats
PDF